CONNEXT Co.
Latest round
- Series C
Last raised
- Mar 2026
Total raised
- $17M
Investors
- 7
About CONNEXT Co.
, Ltd. operates as a clinical-stage biotech company that focused on developing biological therapeutics., Ltd., Ltd. product portfolio includes medicinal recombinant protein products with a primary focus on two technologies: recombinant TLR5 agonist includes CNT101, and CNT102, therapeutic agents designed to prevent side effects associated with radiation and chemotherapy; and recombinant collagenase such as CNT201, and CNT202 designed for the treatment of Peyronie's disease, cellulite, and wound debridement.
Who invested in CONNEXT Co.
7 investors across 2 rounds
See all investors in CONNEXT Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CONNEXT Co.
Who invested in CONNEXT Co.?
CONNEXT Co. has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CONNEXT Co. raised?
CONNEXT Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did CONNEXT Co. last raise money?
CONNEXT Co.'s most recent round on record is a Series C, in Mar 2026.
What does CONNEXT Co. do?
CONNEXT Co. is a biotechnology company.
Where is CONNEXT Co. headquartered?
CONNEXT Co. is headquartered in Daegu, South Korea.
Which VCs invest in companies like CONNEXT Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at CONNEXT Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like CONNEXT Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.